Blog Post
07/31/2017
By Jonathan A. Havens

On July 28, 2017, the U.S. Food and Drug Administration (FDA or the Agency) announced a new, comprehensive plan for tobacco and nicotine regulation that will place nicotine, and the issue of addiction, at the center of the Agency’s tobacco regulatory efforts.

Blog Post
07/20/2017
By Jonathan A. Havens

The Federal Trade Commission (FTC or the Commission) announced a wave of reforms this week in line with Acting Chairman Maureen K. Ohlhausen’s mission to “aggressively” implement a Trump administration directive aimed at eliminating wasteful, unnecessary regulations and processes.

Blog Post
06/21/2017
By Jonathan A. Havens

On June 15, 2017, U.S. Food and Drug Administration (FDA or the Agency) Commissioner Dr. Scott Gottlieb announced that the Agency is developing a new Digital Health Innovation Plan (the Plan), through which FDA hopes to encourage industry growth by providing more regulatory certainty to device developers. Gottlieb also indicated that the Agency will soon pilot a new, risk-based approach toward regulating digital health technologies.

To read more, click here.